Oncogenic deregulation of MYC is observed in the vast majority (~70%) of human malignancies including breast, colon, cervix, lung, bone, brain, and blood cancers [8], [101*, 120*, 141*, 163*, 175*, 178*], globally accounting for one-seventh of all cancer deaths [118*]. Here, MYC is linked to cancer.